Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “meloxicam”

106 pharma patents match "meloxicam" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 106
Index total 30,257
Page 5 / 5

Quick answer

This filtered view shows 106 pharmaceutical patents matching "meloxicam" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

106 results for “meloxicam” · 30,257 patents in full index Clear search

  1. US 10265324

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  2. US 10265399

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  3. US 10265400

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  4. US 10195279

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  5. US 10195278

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  6. US 10137131

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  7. US 10058614

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  8. US 9821075

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  9. US 8765717

    Meloxicam and glucosamine formulation and uses thereof

    Monte Verde S.A. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  10. US 7572641

    Pharmaceutical compositions comprising meloxicam and methods of their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.